MORPHOTEK
Morphotek is one of the leading companies in the life science industry that develops novel classes of biological-based products to treat cancer, inflammation and infectious diseases. Since its founding in 2000, Morphotek has made extraordinary progress in discovering and developing monoclonal antibodies (mABs) to treat these diseases and continues to develop additional antibody products using its proprietary technologies. Post-graduate research executed by Morphotekโs President and CEO, Dr.... Nicholas Nicolaides, during his studies at Johns Hopkins Medical School was the basis for the companyโs inception. It was there that Dr. Nicolaides co-invented the company's legacy technology called morphogenics. Along with the honed applications for applying morphogenics for product development refined by the companyโs other co-founders, Dr. Philip Sass and Dr. Luigi Grasso, morphogenics has taken Morphotek an incredible distance in the advancement of novel pharmaceutical products and targets.
MORPHOTEK
Industry:
Biotechnology Innovation Management Medical
Founded:
1999-01-01
Address:
Exton, Pennsylvania, United States
Country:
United States
Website Url:
http://www.morphotek.com
Total Employee:
51+
Status:
Active
Contact:
(610) 423-6100
Email Addresses:
[email protected]
Total Funding:
78.5 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS DocuSign Cisco Ironport Cloud Internet Names For Business XO Communications
Similar Organizations
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2011-03-04 | TransMolecular | TransMolecular acquired by Morphotek | N/A |
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Morphotek
Hunt BioVentures
Hunt BioVentures investment in Series D - Morphotek
CB Health Ventures
CB Health Ventures investment in Series D - Morphotek
SR One
SR One investment in Series D - Morphotek
Flagship Pioneering
Flagship Pioneering investment in Series D - Morphotek
MDS Capital
MDS Capital investment in Series D - Morphotek
Forward Ventures
Forward Ventures investment in Series D - Morphotek
Investor Growth Capital Limited
Investor Growth Capital Limited investment in Series D - Morphotek
Rock Maple Ventures
Rock Maple Ventures investment in Series D - Morphotek
Morgenthaler Ventures
Morgenthaler Ventures investment in Series D - Morphotek
Official Site Inspections
http://www.morphotek.com
- Host name: 162-244-194-226.bobbroadband.com
- IP address: 162.244.194.226
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago